Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
Apply
Pembrolizumab, Carboplatin, Paclitaxel
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step